Figure 3
CLL-specific expression and enzymatic activity of UGT2B17. (A) UGT family expression profiling in MEC-1, (B) UGT2B isoform expression in CLL patients (n = 19), and (C) functional UGT2B17 shRNA knockdown in MEC-1 (mean of 3 replicates).
CLL-specific expression and enzymatic activity of UGT2B17. (A) UGT family expression profiling in MEC-1, (B) UGT2B isoform expression in CLL patients (n = 19), and (C) functional UGT2B17 shRNA knockdown in MEC-1 (mean of 3 replicates).
